Cefazolin-Related Acute Interstitial Nephritis with Associated Nephrotic-Range Proteinuria: A Case Report

por Xu, Ang, Hyman, David, Lu, Lee Bach
Publicado 2018

Evaluation of Unreimbursed Medicaid Costs Among Nonprofit and For-Profit US Hospitals

por Bai, Ge, Zare, Hossein, Hyman, David A.
Publicado 2022

Picking the Right Patient for Human Epidermal Growth Factor Receptor 3–Targeted Therapy in Platinum-Resistant Ovarian Cancer

por Schram, Alison M., Iasonos, Alexia, Hyman, David M.
Publicado 2016

Precision oncology: Charting a path forward to broader deployment of genomic profiling

por Schram, Alison M., Berger, Michael F., Hyman, David M.
Publicado 2017

Association of Past and Future Paid Medical Malpractice Claims

por Hyman, David A., Lerner, Joshua, Magid, David J., Black, Bernard
Publicado 2023

Primary debulking surgery for metastatic cervical adenocarcinoma: A case report

por Davenport, Sara M., Suidan, Rudy S., Huang, James, Hyman, David M., Chi, Dennis S.
Publicado 2015

Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncology

por Ji, Yan, Jin, Jin Y., Hyman, David M., Kim, Geoffrey, Suri, Ajit
Publicado 2018

Discovery through clinical sequencing in oncology

por Donoghue, Mark T.A., Schram, Alison M., Hyman, David M., Taylor, Barry S.
Publicado 2020

Dual Therapy Appears Superior to Monotherapy for Low-Income Individuals With Newly Diagnosed Type 2 Diabetes

por Vaughan, Elizabeth M., Johnston, Craig A., Hyman, David J., Hernandez, Daphne C., Hemmige, Vagish, Foreyt, John P.
Publicado 2017

A Telehealth-supported, Integrated care with CHWs, and MEdication-access (TIME) Program for Diabetes Improves HbA1c: a Randomized Clinical Trial

por Vaughan, Elizabeth M., Hyman, David J., Naik, Aanand D., Samson, Susan L., Razjouyan, Javad, Foreyt, John P.
Publicado 2020

Basket Trials in Oncology: A Trade-Off Between Complexity and Efficiency

por Cunanan, Kristen M., Gonen, Mithat, Shen, Ronglai, Hyman, David M., Riely, Gregory J., Begg, Colin B., Iasonos, Alexia
Publicado 2017

Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease

por Diamond, Eli L., Hatzoglou, Vaios, Patel, Sneha, Abdel-Wahab, Omar, Rampal, Raajit, Hyman, David M., Holodny, Andrei I., Raj, Ashish
Publicado 2016

A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours

por Schram, Alison M., Gandhi, Leena, Mita, Monica M., Damstrup, Lars, Campana, Frank, Hidalgo, Manuel, Grande, Enrique, Hyman, David M., Heist, Rebecca S.
Publicado 2018

Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAF(V600) mutated malignancies

por Momtaz, Parisa, Pentsova, Elena, Abdel-Wahab, Omar, Diamond, Eli, Hyman, David, Merghoub, Taha, You, Daoqi, Gasmi, Billel, Viale, Agnes, Chapman, Paul B.
Publicado 2016

Tyrosine 870 of TLR9 is critical for receptor maturation rather than phosphorylation-dependent ligand-induced signaling

por Biswas, Chhanda, Rao, Sheila, Slade, Katharine, Hyman, David, Dersh, Devin, Mantegazza, Adriana R., Zoltick, Philip W., Marks, Michael S., Argon, Yair, Behrens, Edward M.
Publicado 2018

Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials

por Hyman, David M., Eaton, Anne A., Gounder, Mrinal M., Pamer, Erika G., Pettiford, Jasmine, Carvajal, Richard D., Ivy, S. Percy, Iasonos, Alexia, Spriggs, David R.
Publicado 2015

Response to Selective RET Inhibition With LOXO-292 in a Patient With RET Fusion-Positive Lung Cancer With Leptomeningeal Metastases

por Guo, Robin, Schreyer, Mark, Chang, Jason C., Rothenberg, S. Michael, Henry, Dahlia, Cotzia, Paolo, Kris, Mark G., Rekhtman, Natasha, Young, Robert J., Hyman, David M., Drilon, Alexander
Publicado 2019

Larotrectinib Demonstrates CNS Efficacy in TRK Fusion-Positive Solid Tumors

por Rosen, Ezra Y., Schram, Alison M., Young, Robert J., Schreyer, Mark W., Hechtman, Jaclyn F., Shu, Catherine A., Ku, Nora C., Hyman, David M., Drilon, Alexander
Publicado 2019

Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion

por Rao, Thapi D., Tian, Huasong, Ma, Xun, Yan, Xiujun, Thapi, Sahityasri, Schultz, Nikolaus, Rosales, Nestor, Monette, Sebastien, Wang, Amy, Hyman, David M., Levine, Douglas A., Solit, David, Spriggs, David R.
Publicado 2015

Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis

por Italiano, Antoine, Nanda, Shivani, Briggs, Andrew, Garcia-Foncillas, Jesus, Lassen, Ulrik, Vassal, Gilles, Kummar, Shivaani, van Tilburg, Cornelis M., Hong, David S., Laetsch, Theodore W., Keating, Karen, Reeves, John A., Fellous, Marc, Childs, Barrett H., Drilon, Alexander, Hyman, David M.
Publicado 2020